MDMA: A Cure for Post-Traumatic Stress Disorder?

MDMA (3,4-Methylenedioxymethamphetamine) has been a resounding success in alleviating and outright curing Post Traumatic Stress Disorder in the afflicted participants when consumed under the right conditions. While the substance often gets a bad wrap for it’s perceived mortality rate (which is usually exaggerated or false) when compared to other substances being using in clinical research, when done in the proper set and setting, the drug can be extremely beneficial for the user.

One common misconception about MDMA is that it is the same as it’s street variations, E, Ex, Molly, Ecstasy, etc. The substance in it’s pure, laboratory grade form is very safe because it isn’t “stepped on” or “cut” with any harmful chemicals to stretch out the product. If you are taking street variations of the substance, there is a much higher chance that what you’re getting isn’t just MDMA (MSM powder used for joint pain and relief is an example of a substance used to cut pill and powder based stimulants). This has also been an issue with research chemicals like 25-i and other NBOmes being sold as LSD on the street. While there are testing kits available, it is unrealistic to assume that the average user is going to have one on hand or be aware that they even exist, which is a a clear cut example of why a safe and legal free-market should be created for this class of substances. 

There are also several other psychological benefits associated with the consumption of MDMA including but not limited to: A decrease in symptoms synonymous with depression, ego dissolution, increased sensitivity to auditory and visual stimuli, a stronger desire to connect with those around the user (physically and spiritually), and it can also act as an anxiolytic (or anxiety reliever) when the proper dosage is used in a clinical setting.

With these breakthroughs becoming more widely understood by the scientific community (the underground and counter-culture movements have posited these sorts of effects for decades now) we should be able to, at the very least, allow for more psychopharmacological study.

In a society that has become obsessed with empiricism (and rightfully so to some extent) it is almost unfathomable that we are ignoring the research data that is being provided to us by way of highly reputable organizations like MAPS. While I am a still a bit disappointed with the legal hoops associated with psychedelic research, it is a step in the right direction and gives me some hope that there will someday be a legal option for those in need of MDMA.

Currently, MAPS is pushing for the legalization and funding of MDMA research. You can support them here.